EP3442600
Kirtiltengd veiruferjudreifing á B-sarkóglýkan og míkróRNA-29 og meðhöndlun á vöðvakyrkingi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.4.2017EP published:
13.3.2024EP application number:
17783207.8
EP translation filed:
6.5.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
13.4.2037Expiry date:
13.4.2026Next due date:
30.4.2026
Title in English:
ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF B-SARCOGLYCAN AND MICRORNA-29 AND THE TREATMENT OF MUSCULAR DYSTROPHYLanguage of the patent:
English
Timeline
Today
14.4.2017EP application
13.3.2024EP Publication
6.5.2024Translation submitted
15.6.2024Registration published
13.4.2026Expires
Owner
Name:
Research Institute at Nationwide Children's HospitalAddress:
700 Children's Drive, Room W172,, Columbus, Ohio 43205, US
Inventor
Name:
RODINO-KLAPAC, LouiseAddress:
Groveport,OH 43125, US
Name:
MENDELL, Jerry, R.Address:
Columbus,OH43235, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662323333 PDate:
15.4.2016Country:
US
Number:
201662433548 PDate:
13.12.2016Country:
US
Classification
Categories:
A61K 48/00, A61P 21/00, C07K 14/47, C12N 15/12, C12N 15/85
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 15.4.2024
Expires: 13.4.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 2.4.2025
Expires: 13.4.2026
Payer: Árnason Faktor ehf.